Showing results (51-60 of 281) with videos related to
Sort By:
Pageof 29
Clinical Pharmacology and Therapeutics|July 1, 1995
Pharmacokinetics and pharmacodynamics of 21-day continuous oral etoposide in pediatric patients with solid tumorsD S Sonnichsen, R C Ribeiro, X Luo, et al.Rheumatology (Oxford, England)|November 8, 2002
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging fieldC Siva, W M Yokoyama, H L McLeodCancer Chemotherapy and Pharmacology|January 29, 1999
Pharmacokinetics of paclitaxel in an anephric patientM H Woo, D Gregornik, P D Shearer, et al.British Journal of Clinical Pharmacology|September 1, 1991
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 29, 2000
Thioguanine substitution alters DNA cleavage mediated by topoisomerase IIN F Krynetskaia, X Cai, J L Nitiss, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokineticsM V Relling, R R Evans, S Groom, et al.Journal of Paediatrics and Child Health|February 1, 1997
Cytochrome P450 2D6 and glutathione S-transferase genotype in sudden infant death syndromeC L Chen, Q Liu, W E Evans, et al.The British Journal of Surgery|August 29, 2003
Cyclo-oxygenase 2 inhibition in colorectal cancer therapyR D Church, J W Fleshman, H L McLeodClinical Pharmacology and Therapeutics|September 6, 2012
Pharmacogenomics and individualized medicine: translating science into practiceK R Crews, J K Hicks, C-H Pui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumorsD S Sonnichsen, C A Hurwitz, C B Pratt, et al.Pageof 29